Get all your news in one place.
100’s of premium titles.
One app.
Start reading
St. Louis Post-Dispatch
St. Louis Post-Dispatch
Bryce Gray

Monsanto shareholders approve merger with Bayer

ST. LOUIS _ Monsanto shareholders voted to approve the agribusiness company's proposed merger with Bayer at a special meeting Tuesday morning.

Monsanto, headquartered outside St. Louis, reported that approximately 99 percent of votes cast supported the German pharmaceutical company's acquisition, which was originally announced in September.

The vote assures shareholders of receiving $128 per share upon completion of the merger. Shareholders also supported certain compensation for executives related to the merger's completion.

"This is a really significant milestone" said Monsanto's chairman and chief executive officer, Hugh Grant, following the meeting. "When you get 99 percent affirmation, that's very encouraging."

Executives from both companies have touted the merger as a way to provide farmers with an improved innovation pipeline needed to address agricultural issues ranging from climate change to food scarcity.

"The test will be: Did we produce better products faster?" said Grant. "Did we help them lift yields?"

While acknowledging that "price is always important," Grant said he believes the complementary nature of the two companies ultimately helped garner support among shareholders.

"It's about bringing bright people together," said Grant. "Combining the two companies unlocks a whole new level of resourcing."

While many wonder what those combined resources will mean for the new company's presence in St. Louis, Grant said ongoing talks with Bayer have reassured him that the region will retain its stature as a biotech hub going forward.

"The more we interact and the more we talk, the better we feel about that," said Grant. "St. Louis will become the global headquarters for all the work on seeds and biotechnology."

The deal is projected to close by the end of 2017 and still needs to be approved by anti-trust regulators. Grant said Bayer has already made regulatory filings in the U.S. and intends to do so in Europe in early 2017. Brazil, India and China represent other key markets where the deal must be upheld, Grant said.

He expressed confidence that the proposed merger would hold up in all jurisdictions, given the differences between the two companies.

"The overlap between the two is really quite small," Grant said.

Others, however, have argued that a finalized merger would consolidate too much market share within one company.

"The existence of such a powerful player would substantially harm both farmers and the environment by decreasing competition and innovation, resulting in increased costs, and allowing for greater corporate control over farmers' planting choice," the Natural Resources Defense Council, an environmental organization, said in a statement.

The organization filed a letter with the U.S. Department of Justice opposing the measure.

With Bayer as a leading pesticide manufacturer, NRDC also voiced concern that the move reinforces "chemical-intensive growing practices" harmful to the environment, and especially pollinators, like bees.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.